| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/06/1996 | CA2133514A1 Restorative neuropharmacological agent for motor and speech disturbance |
| 01/04/1996 | WO1996000082A1 Medical use of bromelain |
| 01/04/1996 | WO1996000077A1 Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 01/04/1996 | WO1996000066A1 Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 01/04/1996 | WO1996000064A1 Therapeutical compositions comprising 3-phenyl-3-hydroxypiperidines |
| 01/04/1996 | WO1996000063A1 Utilisation of derivatives of 1,2,5,6-tetrahydropyridine for the preparation of sedative medicaments |
| 01/04/1996 | WO1996000047A1 Subcutaneous implant |
| 01/04/1996 | WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 01/04/1996 | DE4428152A1 Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung New amido quinoxalinediones, their preparation and use |
| 01/04/1996 | CA2193695A1 Therapeutical compositions comprising 3-phenyl-3-hydroxypiperidines |
| 01/04/1996 | CA2193654A1 Medical use of bromelain |
| 01/04/1996 | CA2193397A1 Utilisation of derivatives of 1,2,5,6-tetrahydropyridine for the preparation of sedative medicaments |
| 01/03/1996 | EP0689839A2 Use of inhibitors of adenosine triphosphatase for the manufacture of a medicament for the treatment of disorders anociated with beta-amyloid peptide |
| 01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 01/03/1996 | EP0689539A1 Antipsychotic indazole derivatives |
| 01/03/1996 | EP0689536A1 Naphthalene derivatives |
| 01/03/1996 | EP0689535A1 Benzimidazole derivatives |
| 01/03/1996 | EP0689534A1 Amide derivatives as 5-ht 1a? ligands |
| 01/03/1996 | EP0689440A1 Use of triazine compounds as anxiolytics |
| 01/03/1996 | EP0689439A1 Use of triazine compounds for the treatment of memory and learning disorders |
| 01/03/1996 | EP0689438A1 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
| 01/03/1996 | EP0689434A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 01/03/1996 | EP0619806B1 Preparation of substituted piperidines |
| 01/03/1996 | EP0553130B1 Pyrrolidine dione derivatives |
| 01/03/1996 | EP0502169B1 Piperazine derivatives |
| 01/02/1996 | US5480983 Adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 01/02/1996 | US5480910 Chemical compounds |
| 01/02/1996 | US5480905 Benzodioxane derivatives |
| 01/02/1996 | US5480892 (N-phthalimidoalkyl)piperidines |
| 01/02/1996 | US5480884 For treating neuropathies and myopathies |
| 01/02/1996 | US5480652 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation |
| 01/02/1996 | US5480645 Hydroxyamines N-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena |
| 01/02/1996 | CA2086335C Pyridopyrazine derivatives for treating substance abuse and addiction |
| 01/02/1996 | CA2053247C 5-aminocarbonyl-5h-dibenzo(a,d)cyclohepten-5, 10-imines for treatment of epilepsy and cocaine addiction |
| 12/31/1995 | CA2152765A1 Methods for treating a physiological disorder associated with beta amyloid peptide |
| 12/28/1995 | WO1995035316A1 New opioid peptide antagonists |
| 12/28/1995 | WO1995035314A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 12/28/1995 | WO1995035310A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 12/28/1995 | WO1995035308A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 12/28/1995 | WO1995035300A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 12/28/1995 | WO1995035293A1 Indol derivatives useful for the treatment of migraine, composition and utilization |
| 12/28/1995 | WO1995035289A1 Novel amido quinoxaline diones, their production and use |
| 12/28/1995 | WO1995035105A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 12/28/1995 | WO1995032203A3 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 12/28/1995 | CA2193732A1 Novel amido quinoxaline diones, their production and use |
| 12/28/1995 | CA2193644A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 12/28/1995 | CA2193100A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 12/28/1995 | CA2192484A1 New opioid peptide antagonists |
| 12/28/1995 | CA2169050A1 Indol derivatives useful for the treatment of migraine, composition and utilization |
| 12/27/1995 | EP0688334A1 Oligodendroglial trophic factor and methods of use thereof |
| 12/27/1995 | EP0688331A1 New sulfated lyso-ganglioside derivatives |
| 12/27/1995 | EP0688330A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 12/27/1995 | EP0688320A1 Tricyclic benzodiazepins, their use and preparation |
| 12/27/1995 | EP0688319A1 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
| 12/27/1995 | EP0688312A1 New derivatives of glutamic acid, a method of preparing them, and their use as drugs for enhancing memory and learning |
| 12/27/1995 | EP0575442B1 Tetracyclic imidazoquinazoline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/27/1995 | EP0556218B1 Local anaesthetic |
| 12/27/1995 | EP0553351B1 CRYSTALLINE MODIFICATION OF HYDROCHLORIDE OF 2-DIMETHYLAMINOETHYL ETHER OF n-BUTYLAMINO BENZOIC ACID, METHOD OF OBTAINING IT AND PHARMACEUTICAL PREPARATION FOR ANESTHESIA OF THE EYE BASED THEREUPON |
| 12/27/1995 | EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity |
| 12/27/1995 | CN1113911A Therapuetic agents |
| 12/27/1995 | CN1113765A preparation for protecting liver and relieving acute alcoholism and its preparing method |
| 12/26/1995 | US5478956 8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them |
| 12/26/1995 | US5478941 Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine |
| 12/26/1995 | US5478938 Antagonists for angiotensin II receptors; hypotensive, cardiotonic agents; cognitive activators |
| 12/26/1995 | US5478857 Use of PLA2 inhibitors as treatment for alzheimer's disease |
| 12/26/1995 | US5478856 Styrene derivatives and salts thereof |
| 12/26/1995 | US5478852 Administering |
| 12/26/1995 | US5478828 Piperazinyl-and piperidinyl-cyclohexanols |
| 12/26/1995 | US5478577 Administering controlled release dosage form of opiate analgesics |
| 12/26/1995 | US5478572 Cellulosic polymer matrix and excipients; extended release; side effect reduction; antidepressants and anxiolytic agents |
| 12/26/1995 | US5478565 Treatment of sinus headache |
| 12/26/1995 | CA2094805C Certain imidazoquinoxalines; a new class of gaba brain receptor ligands |
| 12/26/1995 | CA2028746C Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
| 12/26/1995 | CA1337817C Heterocyclic spiro compounds and methods for preparing the same |
| 12/21/1995 | WO1995034651A2 Corticotropin-releasing factor2 receptors |
| 12/21/1995 | WO1995034563A1 Pyrazolo and pyrrolopyridines |
| 12/21/1995 | WO1995034561A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 12/21/1995 | WO1995034556A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 12/21/1995 | WO1995034555A1 Benzimidazolone derivatives with central dopaminergic activity |
| 12/21/1995 | WO1995034547A1 C-4 amide substituted compounds and their use as therapeutic agents |
| 12/21/1995 | WO1995034546A1 Benzopyrans and their use as therapeutic agents |
| 12/21/1995 | WO1995034545A1 Benzopyrans and their use as therapeutic agents |
| 12/21/1995 | WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 12/21/1995 | WO1995034306A1 Use of immunosuppressive agents for the treatment of schizophrenia |
| 12/21/1995 | WO1995034304A1 Pharmacologically active 2-mercaptobenzimidazole derivatives |
| 12/21/1995 | WO1995027066A3 Dna encoding ubiquitin conjugating enzymes |
| 12/21/1995 | WO1995022965A3 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 12/21/1995 | WO1995018616A3 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor |
| 12/21/1995 | CA2576396A1 Adeno-associated virus materials and methods |
| 12/21/1995 | CA2193072A1 Corticotropin-releasing factor2 receptors |
| 12/21/1995 | CA2192460A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 12/21/1995 | CA2190611A1 Covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives |
| 12/20/1995 | EP0687681A1 Immunogens for the production of cocaine-hydrolyzing catalytic antibodies |
| 12/20/1995 | EP0687268A1 Spiroazacyclic derivatives as substance p antagonists |
| 12/20/1995 | EP0687267A1 Pyrrolo-pyridine derivatives |
| 12/20/1995 | EP0687266A1 Heterocyclic compounds and their preparation and use |
| 12/20/1995 | EP0687265A1 Heterocyclic compounds and their preparation and use |
| 12/20/1995 | EP0687255A1 Quinolone derivatives as dopamine d4 ligands |
| 12/20/1995 | EP0687252A1 2-phenoxyethylamine derivatives, their preparation and their therapeutical use |
| 12/20/1995 | EP0687251A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |